IDEAYA Biosciences, Inc. (NASDAQ:IDYA) appears in 239 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 14,530,506 | 7,344,050 | 102.19% | $484,046,028.00 |
| FMR LLC | 31 Mar, 2026 | 13,172,103 | 22,143 | 0.17% | $438,894,479.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 8,442,133 | 232,741 | 2.84% | $281,291,873.00 |
| Capital Research Global Investors | 31 Mar, 2026 | 5,163,543 | -116,132 | -2.20% | $172,049,253.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 3,946,515 | 327,689 | 9.06% | $131,497,880.00 |
| State Street Corp | 31 Mar, 2026 | 3,781,167 | -353,474 | -8.55% | $125,988,484.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,732,422 | 3,732,422 | 0.00% | $124,364,301.00 |
| Logos Global Management LP | 31 Mar, 2026 | 3,450,000 | 325,000 | 10.40% | $114,954,000.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 2,987,107 | -408,664 | -12.03% | $99,530,405.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 2,823,500 | 23,500 | 0.84% | $94,079,020.00 |
| Fiera Capital Corp | 31 Mar, 2026 | 2,527,076 | 89,814 | 3.69% | $84,202,173.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,500,724 | 427,141 | 20.60% | $83,337,454.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,860,453 | 608,049 | 48.55% | $61,990,332.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,655,617 | -1,886,115 | -53.25% | $55,165,159.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 1,530,008 | -623,035 | -28.94% | $50,979,867.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,333,478 | 394,621 | 42.03% | $44,417,991.00 |
| GSK plc | 31 Mar, 2026 | 1,333,333 | 0 | 0.00% | $44,426,656.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 1,315,869 | 1,315,869 | 0.00% | $43,845.00 |
| Sofinnova Investments, Inc. | 31 Mar, 2026 | 1,131,786 | 246,665 | 27.87% | $37,711,110.00 |
| Candriam S.C.A. | 31 Mar, 2026 | 1,107,708 | 76,354 | 7.40% | $36,908,831.00 |